RxDoctor Payments Data

Diana Medgyesy, MD

Medical Oncology · Fort Collins, CONPI 1083660708

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $121 of the $148 with a category attached, or 82.2%. Gilead accounts for 90.3% of it on its own, with 1 other manufacturer making up the rest. 2023 is the largest year on record at $121, 8.4 times the $14 reported in 2019. That places this record below the midpoint for medical oncology clinicians in CO, where the typical reported total is $1,342.

$148in general payments, 2019–2025

Across 3 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$133
  • Clovis Oncology, Inc.$14
$3,508,409in research payments, 2019–2025

Across 140 payments — averaging $25,060 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2.6M
  • Seagen Inc.$684K
  • Radius Health, Inc.$225K
  • Stemline Therapeutics Inc.$37K
  • Merck$4K
  • Puma Biotechnology, Inc.$3K
  • plus $143 from 1 others

What the payments were for

  • Food & beverage$12182%
  • Education$2618%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead(2 entities)2$133
Clovis Oncology, Inc.1$14

How this compares

$148 in reported general payments places this provider in the 20th percentile of 96 medical oncology providers in Colorado.

See all medical oncology providers in Colorado

Medicare billing

Part B allowed, 2024
$39,437
Medicare patients
127
Services billed
364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →